🔎 Trials Near Me

Pradžia › Inksto nepakankamumas › Tennessee

Inksto nepakankamumas klinikiniai tyrimai Tennessee

7 tyrimai dėl Inksto nepakankamumas ieško dalyvių vietose Tennessee.

Miestai Tennessee

Oficialus tyrimo tekstas (anglų kalba)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Southeast Renal Research Institute, Chattanooga
  • Dialysis Clinic Inc - University Nephology, Knoxville
  • Knoxville Kidney Center PLLC, Knoxville
  • ir dar 2
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05485961

Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)

  • Memphis VA Medical Center, Memphis, TN, Memphis
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-20 · NCT05465044

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

  • Vascular Institute of Chattanooga, Chattanooga
  • Bluff City Vascular, Memphis
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-10 · NCT04634916

Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants

  • Nephrology Associates of Knoxville, Knoxville
Renkami dalyviai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-07-06 · NCT06613568

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

  • Galen Medical Group, Chattanooga
Renkami dalyviai
Amžius nuo 18 iki 84 · Visoms lytims · Atnaujinta 2026-04-13 · NCT06190717

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

  • James Eric Gardner, MD, PC, Memphis
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-17 · NCT06001827

CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease

  • Vanderbilt University Medical Center-GCRC, Nashville
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-01-02 · NCT05422534

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.